CCSD code G0260 – Endoscopically assisted oesophagectomy

Key takeaways

CCSD code G0260 covers endoscopically assisted oesophagectomy only, and open resection is coded separately.

The operative note must state the endoscopic approach, the instruments and each operative phase to support the claim.

Most UK private insurers require pre-authorization before G0260 is performed, and a missing reference is the leading denial trigger.

Oesophageal malignancy (ICD-10 category C15) is the primary diagnosis pairing for G0260.

Barrett’s oesophagus (K22.7 in UK ICD-10) is also accepted when high-grade dysplasia is documented and endoscopic therapy has failed.

Pabau, the practice management platform we build, supports CCSD-coded claims with structured documentation and insurer submission tracking.

What is CCSD code G0260?

CCSD code G0260 is the procedure code for endoscopically assisted oesophagectomy, the minimally invasive removal of all or part of the oesophagus. UK private medical insurers use it to pay surgeons for Ivor Lewis and McKeown resections performed thoracoscopically and laparoscopically.

The Clinical Coding and Schedule Development (CCSD) Group maintains the schedule. All major UK private medical insurers, including Bupa, AXA Health, Aviva, Vitality and Cigna, use it as the standard framework for procedure billing. Surgeons billing privately submit G0260 when the operative record confirms an endoscopic approach throughout, or for the primary phase of the procedure.

G0260 sits in CCSD chapter 8, Thorax and Intra-Thoracic Organs (8.1.0 Oesophagus). It is distinct from the open oesophagectomy codes in the same chapter, which our full CCSD codes index lists side by side.

The code descriptor is specific to endoscopic assistance. A G0260 claim for a procedure performed entirely through open access will not survive audit or insurer review. According to the CCSD Technical Guide (October 2025), the code must reflect the surgical technique documented in the operative record, not the intended technique.

What the procedure involves: Endoscopically assisted oesophagectomy

Endoscopically assisted oesophagectomy typically involves two coordinated phases performed under general anesthesia, most commonly in the context of oesophageal cancer resection.

• Thoracoscopic phase: The chest is accessed using video-assisted thoracoscopic surgery (VATS). The thoracic oesophagus is mobilized from the mediastinum, and mediastinal lymphadenectomy is performed under direct camera vision.
• Laparoscopic abdominal phase: The stomach is mobilized laparoscopically. A gastric conduit (gastric tube or pull-up) is fashioned to serve as the oesophageal replacement.
• Reconstruction: The gastric conduit is pulled through the mediastinum and joined to the remaining oesophagus. The anastomosis sits in the neck in a McKeown (three-phase) approach, or in the chest in an Ivor Lewis (two-phase) approach.
• Specimen handling: The resected oesophagus with lymph nodes is removed and sent for histopathological analysis. Accurate specimen description in the operative note supports both pathology coding and the G0260 claim.

The Ivor Lewis oesophagectomy pairs a thoracoscopic chest phase with a laparoscopic abdominal phase and an intrathoracic anastomosis. The McKeown oesophagectomy adds a cervical anastomosis phase. Both are eligible for G0260 when performed endoscopically. A transhiatal oesophagectomy performed without thoracoscopic access is not captured by G0260.

Clinical indications: When is G0260 appropriate?

G0260 is appropriate when oesophagectomy is clinically justified and performed endoscopically. Insurers assess medical necessity against published guidelines, most notably NICE guideline NG83 on oesophago-gastric cancer. NG83 recommends surgery for resectable oesophageal and junctional tumors in patients fit for major surgery.

• Oesophageal malignancy: Squamous cell carcinoma or adenocarcinoma staged as resectable (typically T1-T3, N0-N1, M0 following staging CT and PET-CT). This is the primary indication driving the majority of G0260 claims.
• Barrett’s oesophagus with high-grade dysplasia: When endoscopic mucosal resection or ablation has failed or is not appropriate, surgical resection may be indicated.
• Benign oesophageal stricture: Unresponsive to repeated dilatation, particularly when associated with significant dysphagia or aspiration risk.
• Achalasia (end-stage): Rare indication where oesophageal function is irretrievably lost and resection is preferred over myotomy.

When achalasia is treated with a thoracoscopic myotomy instead, the oesophagus stays in place and the procedure is billed as G0922, not G0260.

Each insurer may apply its own criteria on top of these indications. Staging information, MDT minutes and the referring oncologist’s letter should accompany the pre-authorization request.

G0260 vs related CCSD codes: Choosing the right code

The most consequential coding decision for oesophagectomy is the approach, open or endoscopic. Selecting the wrong code is both a claim integrity issue and a potential audit trigger. The table below compares G0260 against the most commonly confused adjacent codes.

Approach variants and their impact on code selection

Both the Ivor Lewis (two-phase, intrathoracic anastomosis) and McKeown (three-phase, cervical anastomosis) oesophagectomies are eligible for G0260 when performed thoracoscopically and laparoscopically. The access method determines code eligibility, and the anastomosis level does not change it.

Robotic oesophagectomy coding is still evolving. Some insurers accept G0260 for robot-assisted cases on the basis that the robotic system is an endoscopic instrument platform. Others require a separate robotic supplement code or apply a different fee schedule.

Coders should confirm the individual insurer’s position before claiming G0260 for a robotic case. When the procedure converts from endoscopic to open intraoperatively, the operative note must document the conversion. The claim should then carry the open code rather than G0260.

Neighboring procedures carry their own codes. A total oesophagectomy with interposition of intestine, used when the stomach cannot form the conduit, is billed as G0220.

Excising an oesophageal lesion without resecting the oesophagus is not an oesophagectomy at all. It is billed as G1400 by VATS, or as G0400 through open access. The panel below maps each documented route to the code it supports.

ICD-10 diagnosis codes that pair with G0260

Every G0260 claim requires an ICD-10 diagnosis code to establish the clinical reason for the procedure. The primary pairing codes come from category C15, Malignant neoplasm of oesophagus. Verify codes against current CCSD and insurer guidance for the submission year, as accepted pairings are reviewed annually.

Use the most specific code available. C15.9 should not be used when the operative report and staging document identify the tumor location. UK ICD-10 has no dysplasia split for Barrett’s oesophagus, so K22.7 is paired with a morphology code that records the dysplasia.

The NHS Classifications Browser provides current UK ICD-10 fifth edition code definitions for reference.

G0260 documentation requirements for a valid claim

The operative note is the single most important document for a G0260 claim. Vague or incomplete documentation is the leading cause of denial and audit failure.

The Royal College of Surgeons’ Good Surgical Practice expects operation notes to be completed immediately after surgery. The GMC’s Good Medical Practice requires records made at the time, or as soon as possible afterwards. A delayed or retrospectively amended note weakens the claim, and a structured operative template helps the surgeon capture each element while it is fresh.

The operative note must explicitly address each of the following to support G0260:

• Explicit statement of endoscopic approach: Name the technique used, whether thoracoscopic, video-assisted thoracoscopic (VATS), laparoscopic or robot-assisted. “MIS oesophagectomy” without elaboration is not sufficient for all insurers.
• Instruments and ports: Record the number and placement of thoracoscopic ports and the laparoscopic trocar positions. List any additional instruments used, such as a harmonic scalpel, staplers or clip appliers.
• Phase descriptions: Document each operative phase in sequence. That means thoracoscopic mobilization, laparoscopic gastric preparation, conduit formation, conduit pull-through, anastomotic technique (hand-sewn or stapled) and anastomosis level.
• Mediastinal dissection detail: List the lymph node stations dissected, whether the lymphadenectomy was two-field or three-field, and any intraoperative findings that affected the dissection.
• Anastomosis confirmation: State the type of anastomosis (circular stapler, linear stapler or hand-sewn), whether a leak test was performed, and its result.
• Specimen description: Note the oesophagus length, the attached stomach cuff, the proximal and distal margins, and the lymph nodes included in the specimen.
• Conversion note: If conversion to open occurred, this must be explicitly documented with the reason. The code should then be changed to the appropriate open procedure code before submission.

Prior authorization and medical necessity for G0260

All major UK private medical insurers require pre-authorization before oesophagectomy is performed. Submitting a G0260 claim without a valid authorization reference number is the single most common reason for initial denial. Each insurer maintains its own authorization portal and criteria. The documents below are standard across Bupa, AXA Health, Aviva and Vitality Health.

• Referral documentation: A letter from an oncologist, gastroenterologist, or specialist referring clinician confirming the diagnosis, staging, and MDT recommendation for surgery.
• Staging evidence: CT chest/abdomen/pelvis report, PET-CT report where performed, and endoscopy/biopsy histology confirming malignancy or high-grade dysplasia.
• MDT record: Minutes or outcome letter from the relevant upper GI cancer MDT meeting recommending surgical resection.
• Surgeon’s letter: Consultant’s letter confirming the proposed approach (endoscopic), the clinical indication, and the intended date of surgery.
• Pre-operative fitness assessment: Relevant cardiorespiratory investigations, plus an anesthetic assessment if the insurer requests one.

The Bupa CCSD codes guide covers the submission and authorization requirements for Bupa-insured patients in more detail. For procedure-specific criteria, check each insurer’s own tools, such as the Bupa code search or the Aviva provider fee schedule.

Anesthesia, assistant surgeon and add-on code considerations

Oesophagectomy is a major surgical procedure requiring general anesthesia and, in most cases, a surgical assistant. The billing rules for these supplementary services vary by insurer. The table below summarizes what can typically be claimed alongside G0260 and what is considered bundled.

Several clinicians bill for a single G0260 procedure. Coordinated invoicing between the surgical team, the anesthetist and the hospital reduces the risk of duplicate or conflicting claims.

Common claim denial reasons for G0260 and how to avoid them

G0260 claim denials follow a predictable pattern, and most are preventable with pre-submission checks. Good claims management software flags a missing authorization reference or an incomplete operative note before the invoice reaches the insurer.

• Missing or expired pre-authorization: The most common denial trigger. The authorization reference number must appear on the claim, and the claim must be submitted within the validity window granted. Emergency extensions require separate insurer notification.
• Operative note fails to confirm endoscopic approach: A note that describes only the outcome is not enough. Without the access method, the insurer cannot tell G0260 from an open code. Explicit instrument naming and port placement are required.
• Wrong diagnosis code pairing: Submitting C15.9 (unspecified oesophageal malignancy) when a specific subsite code is available can trigger a medical necessity query. Use C15.4 for the middle third or C15.5 for the lower third, or C15.1 or C15.2 when a thoracic or abdominal site is documented. Similarly, K22.7 (Barrett’s oesophagus) alone does not justify oesophagectomy without documented high-grade dysplasia.
• Unbundling of bundled services: Claiming intraoperative endoscopy as a separate line item alongside G0260 is a common unbundling error. Check the specific insurer’s schedule for bundling rules before itemizing add-on services.
• Conversion to open not reflected: Sometimes the endoscopic approach is converted to open intraoperatively but the claim still shows G0260. The insurer may then deny it for code mismatch. The operative note and claim code must align.
• Assistant surgeon not separately recognized: Some insurers require the first assistant to hold individual recognition with them before a separate assistant-surgeon claim can be processed. Verify recognition status in advance.

Modifier usage with CCSD code G0260

CCSD modifiers supplement the base code to communicate additional clinical or administrative information to the insurer. The modifiers most relevant to G0260 are as follows:

Modifier rules vary between insurers. The CCSD schedule provides the base framework. Individual insurer bulletins, available through the Bupa, AXA, Aviva and Vitality provider portals, specify how each modifier is applied and priced.

Reimbursement and fee benchmarks for G0260 in UK private practice

Oesophagectomy is one of the highest-banded surgical procedures in the CCSD schedule, reflecting its clinical complexity and operative duration. Reimbursement for G0260 depends on the insurer’s fee schedule and on whether the surgeon holds recognized consultant status with that insurer. Any rate negotiated at hospital or individual level also changes the figure.

Fee ranges in UK private practice are not publicly standardized, but consultants can benchmark against several sources. The Healix fee schedule publishes CCSD-based rates and is openly accessible. The Aviva fee schedule is available to recognized Aviva providers and covers the full CCSD surgical chapter. Cigna UK’s schedule is accessible via the Cigna provider portal for recognized consultants.

Key factors affecting G0260 reimbursement in practice:

• Insurer recognition: Consultants without recognition with a specific insurer are typically limited to the insurer’s standard published rate, with any excess billed to the patient.
• Hospital contract: Independent hospitals such as Spire, Nuffield and Circle Health Group hold block contracts or cost-per-case agreements with insurers. The agreement type affects the facility component of the total invoice.
• Complexity uplifts: Some insurers apply complexity indicators for procedures involving oncological resection or technical difficulty. This must be justified in the pre-authorization documentation.
• Annual schedule updates: CCSD fee schedules are reviewed periodically. Ensure the fee cited on the invoice matches the schedule in force at the date of procedure, not a prior year’s figure.

Surgeons new to private practice should obtain recognized status with each insurer before performing insured procedures. Claims from unrecognized consultants are frequently reduced or redirected to the patient. Recognition typically requires a CV, a certificate of good standing and evidence of surgical activity in the relevant subspecialty.

How Pabau keeps G0260 claims and operative notes aligned

A G0260 claim draws on records that often live in different places. The operative note sits in one system, the authorization reference arrives by email, and the invoice is built somewhere else. Every handover is a chance for the approach, the code or the reference to drift apart.

Pabau holds those records on one patient file. Structured treatment notes and forms prompt the surgeon to record the access method and each operative phase. The invoice is then raised against that same record with the CCSD code attached, and sent to the insurer through Healthcode.

The result is a claim the insurer can match to the operative note line by line. Your billing team spends less time answering queries and resubmitting invoices.

Manage CCSD billing from one place

Pabau keeps operative documentation, CCSD-coded invoicing and insurer submission tracking on one patient record, so surgical claims leave complete.

Book a demo

Conclusion

G0260 rewards the surgeon whose paperwork matches the operation. The access method written in the operative note decides the code, so the note deserves the same care as the resection itself.

The trade-off is a few extra minutes at the end of a long list. A complete note written straight after surgery costs little, while defending a vague one through an insurer query can hold up payment for much longer.

Book a demo to see how Pabau links operative notes, authorizations and CCSD invoices for private surgical practices.

Continue your research

Need a full guide to Bupa CCSD coding and submission? Bupa CCSD codes guide covers the full submission process, recognized procedure chapters and Bupa-specific billing rules for private consultants.

Reconstructing with intestine instead of stomach? CCSD code G0220 covers total oesophagectomy with interposition of intestine and how to bill it.

Excising an oesophageal lesion through open access? CCSD code G0400 explains how open excision of a lesion of the oesophagus is coded and claimed.

Treating achalasia without a resection? CCSD code G0922 covers billing for VATS oesophageal and oesophagogastric myotomy.

Frequently asked questions